We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CSSPF market cap is 318.1M. The company's latest EPS is GBP 0.0224 and P/E is 27.86.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 62.4M | 46M | 30.4M | 33.3M | 36.8M |
| Operating Income | -94.7M | -135.5M | -2.4M | 12M | 4.8M |
| Net Income | -48.3M | -33.5M | 3.6M | 16.1M | 9.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 246.8M | 103.1M | 86.4M | 98.5M | 91.5M |
| Total Liabilities | 162M | 37M | 19.6M | 16.6M | 7.7M |
| Total Equity | 84.8M | 66.1M | 66.8M | 81.9M | 83.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -25.1M | -23.9M | 1.4M | 6.7M | 11.6M |
| Investing | -9.9M | -500k | -200k | -100k | -300k |
| Financing | 21.9M | 4.3M | 4.1M | -500k | -10.5M |
| Market Cap | 318.1M |
| Price to Earnings Ratio | 27.86 |
| Price to Sales Ratio | 7.19 |
| Price to Cash Ratio | 13.3 |
| Price to Book Ratio | 3.16 |
| Dividend Yield | - |
| Shares Outstanding | 424.13M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.75 |
| 52 Week Low | 0.75 |
| Spread (Intraday) | 3.3 (100%) |
| Company Name | NIOX Group PLC (PK) |
| Address |
magdalen centre oxford OX4 4GA |
| Website | https://www.niox.com/en-gb/legal-notice |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
